Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cranial bone

Tissue Engineering - Part A

Volumn 18, Issue 19-20, 2012, Pages 2095-2105

  Sun, Hongli ^a   Jung, Younghun ^a   Shiozawa, Yusuke ^a   Taichman, Russell S ^a   Krebsbach, Paul H ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMINERALIZATION; BLOOD; CELL CULTURE; MUSCULOSKELETAL SYSTEM; TISSUE;

ALENDRONATE; ALN; ANGIOGENESIS; BLOOD TRANSFUSION; BONE MARROW; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE VOLUME; CRANIAL BONE; DEFECT MODEL; ERYTHROPOIETIN (EPO); FUNCTIONAL PROPERTIES; IN-VITRO; MESENCHYMAL STEM CELL; ORGAN CULTURE; ORTHOPEDIC SURGERY; OSTEOCLASTOGENESIS; OSTEOPROTEGERIN; PERIPHERAL BLOOD; RED BLOOD CELL;

BONE;

BONE MORPHOGENETIC PROTEIN 2; ERYTHROPOIETIN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; MOUSE; SKULL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; ERYTHROPOIETIN; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; OSTEOGENESIS; SKULL;

EID: 84867024951     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0742     Document Type: Article

References (62)

1. Schliephake, H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31, 469, 2002.
2. Giannoudis, P.V., and Tzioupis, C. Clinical applications of BMP-7\-the UK perspective. Injury 36, 47, 2005.
3. Luhmann, S.J., Bridwell, K.H., Cheng, I., Imamura, T., Lenke, L.G., and Schootman, M. Use of bone morphogenetic protein-2 for adult spinal deformity. Spine 30, S110, 2005.
4. Einhorn, T.A. Clinical applications of recombinant human BMPs: early experience and future development. J Bone Joint Surg Am 85A, 82, 2003.
5. Cahill, K.S., Chi, J.H., Day, A., and Claus, E.B. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 302, 58, 2009.
6. Gautschi, O.P., Frey, S.P., and Zellweger, R. Bone morpho-genetic proteins in clinical applications. Anz J Surg 77, 626, 2007.
7. Scheller, E.L., and Krebsbach, P.H. Gene therapy: design and prospects for craniofacial regeneration. J Dent Res 88, 585, 2009.
8. Hsu, W.K., Sugiyama, O., Park, S.H., Conduah, A., Feeley, B.T., Liu, N.Q., et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone 40, 931, 2007.
9. Nussenbaum, B., Rutherford, R.B., Teknos, T.N., Dornfeld, K.J., and Krebsbach, P.H. Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy. Hum Gene Ther 14, 1107, 2003.
10. Krebsbach, P.H., Gu, K., Franceschi, R.T., and Rutherford, R.B. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11, 1201, 2000.
11. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
12. Wei, G.B., Jin, Q.M., Giannobile, W.V., and Ma, P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28, 2087, 2007.
13. Li, G.H., Corsi-Payne, K., Zheng, B., Usas, A., Peng, H.R., and Huard, J. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A 15, 2123, 2009.
14. Kempen, D.H.R., Lu, L.C., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
15. Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., and Mooney, D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848, 2005.
16. Smith, D.M., Cooper, G.M., Mooney, M.P., Marra, K.G., and Losee, J.E. Bone morphogenetic protein 2 therapy for cra-niofacial surgery. J Craniofac Surg 19, 1244, 2008.
17. Reddi, A.H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16, 247, 1998.
18. Elizabeth, A.W. Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. Trends Bio-technol 11, 379, 1993.
19. Tsumaki, N., and Yoshikawa, H. The role of bone morpho-genetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 16, 279, 2005.
20. Hadjidakis, D.J., and Androulakis, I.I. Bone remodeling. Ann N Y Acad Sci 1092, 385, 2006.
21. Song, J.H., Kiel, M.J., Wang, Z., Wang, J.C., Taichman, R.S., Morrison, S.J., et al. An in vivo model to study and manipulate the hematopoietic stem cell niche. Blood 115, 2592, 2010.
22. Jelkmann, W. Erythropoietin after a century of research: younger than ever. Eur J Haematol 78, 183, 2007.
23. Arcasoy, M.O. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141, 14, 2008.
24. Goodnough, L.T., Monk, T.G., and Andriole, G.L. Ery-thropoietin therapy. N Engl J Med 336, 933, 1997.
25. Zhang, J.W., Niu, C., Ye, L., Huang, H.Y., He, X., Tong, W.G., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836, 2003.
26. Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight, M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841, 2003.
27. Jung, Y., Song, J., Shiozawa, Y., Wang, J., Wang, Z., Williams, B., et al. Hematopoietic stem cells regulate mesen-chymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells 26, 2042, 2008.
28. Shiozawa, Y., Jung, Y., Ziegler, A.M., Pedersen, E.A., Wang, J., Wang, Z., et al. Erythropoietin couples hematopoiesis with bone formation. PLoS One 5, e10853, 2010.
29. Pederson, L., Ruan, M., Westendorf, J.J., Khosla, S., and Oursler, M.J. Regulation of bone formation by osteo-clasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 105, 20764, 2008.
30. Tang, Y., Wu, X.W., Lei, W.Q., Pang, L.J., Wan, C., Shi, Z.Q., et al. TGF-beta 1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15, 757, 2009.
31. Kim, J., Jung, Y., Sun, H., Joseph, J., Mishra, A., Shiozawa, Y., et al. Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem 113, 220, 2012.
32. Kucia, M., Reca, R., Campbell, F.R., Zuba-Surma, E., Majka, M., Ratajczak, J., et al. A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow. Leukemia 20, 857, 2006.
33. Cackowski, F.C., Anderson, J.L., Patrene, K.D., Choksi, R.J., Shapiro, S.D., Windle, J.J., et al. Osteoclasts are important for bone angiogenesis. Blood 115, 140, 2010.
34. Jacobsen, S.E.W., Borge, O.J., Ramsfjell, V., Cui, L., Cardier, J.E., Veiby, O.P., et al. Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells. Stem Cells 14, 173, 1996.
35. Taichman, R.S. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105, 2631, 2005.
36. Zuba-Surma, E.K., Kucia, M., Dawn, B., Guo, Y., Ratajczak, M.Z., and Bolli, R. Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. J Mol Cell Cardiol 44, 865, 2008.
37. Kucia, M., Zhang, Y.P., Reca, R., Wysoczynski, M., Macha-linski, B., Majka, M., et al. Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke. Leukemia 20, 18, 2005.
38. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 354, 453, 2007.
39. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 26, 223, 2008.
40. Roodman, G.D. Cell biology of the osteoclast. Exp Hematol 27, 1229, 1999.
41. Han, D., and Zhang, Q. An essential requirement for oste-oclasts in refined bone-like tissue reconstruction in vitro. Med Hypotheses 67, 75, 2006.
42. Nakagawa, K., Abukawa, H., Shin, M.Y., Terai, H., Troulis, M.J., and Vacanti, J.P. Osteoclastogenesis on tissue-engineered bone. Tissue Eng 10, 93, 2004.
43. Ingber, D.E., Mow, V.C., Butler, D., Niklason, L., Huard, J., Mao, J., et al. Tissue engineering and developmental biology: going biomimetic. Tissue Eng 12, 3265, 2006.
44. Jensen, E.D., Pham, L., Billington, C.J., Espe, K., Carlson, A.E., Westendorf, J.J., et al. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. J Cell Biochem 109, 672, 2010.
45. Kamiya, N., and Mishina, Y. New insights on the roles of BMP signaling in bone\-a review of recent mouse genetic studies. Biofactors 37, 75, 2011.
46. Singbrant, S., Russell, M.R., Jovic, T., Liddicoat, B., Izon, D.J., Purton, L.E., et al. Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood 117, 5631, 2011.
47. Garcia, P., Speidel, V., Scheuer, C., Laschke, M.W., Holstein, J.H., Histing, T., et al. Low dose erythropoietin stimulates bone healing in mice. J Orthop Res 29, 165, 2011.
48. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.-C., Cummins, J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Investig 110, 751, 2002.
49. Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S.R., et al. The hypoxia-inducible factor a pathway couples an-giogenesis to osteogenesis during skeletal development. J Clin Investig 117, 1616, 2007.
50. Kanczler, J.M., Oreffo, R.O.C. Osteogenesis and angiogene-sis: the potential for engineering bone. Eur Cells Mater 15, 100, 2008.
51. Wan, C., Gilbert, S.R., Wang, Y., Cao, X., Shen, X., Ra-maswamy, G., et al. Activation of the hypoxia-inducible factor-1a pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105, 686, 2008.
52. Schipani, E., Maes, C., Carmeliet, G., and Semenza, G.L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res 24, 1347, 2009.
53. Kent Leach, J., Kaigler, D., Wang, Z., Krebsbach, P.H., and Mooney, D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27, 3249, 2006.
54. Anagnostou, A., Lee, E.S., Kessimian, N., Levinson, R., and Steiner, M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial-cells. Proc Natl Acad Sci U S A 87, 5978, 1990.
55. Anagnostou, A., Liu, Z.Y., Steiner, M., Chin, K., Lee, E.S., Kessimian, N., et al. Erythropoietin receptor messenger-RNA expression in human endothelial-cells. Proc Natl Acad Sci U S A 91, 3974, 1994.
56. Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., and Kuck, K.H. Erythropoietin and VEGF exhibit equal angio-genic potential. Microvasc Res 64, 326, 2002.
57. Kertesz, N., Wu, J., Chen, T.H.P., Sucov, H.M., and Wu, H. The role of erythropoietin in regulating angiogenesis. Develop Biol 276, 101, 2004.
58. Holstein, J.H., Menger, M.D., Scheuer, C., Meier, C., Cule-mann, U., Wirbel, R.J., et al. Erythropoietin (EPO)\-EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci 80, 893, 2007.
59. Holstein, J.H., Orth, M., Scheuer, C., Tami, A., Becker, S.C., Garcia, P., et al. Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice. Bone 49, 1037, 2011.
60. Nussenbaum, B., Rutherford, R.B., and Krebsbach, P.H. Bone regeneration in cranial defects previously treated with radiation. Laryngoscope 115, 1170, 2005.
61. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Ferrara, N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99, 9656, 2002.
62. Chan, C.K.F., Chen, C.-C., Luppen, C.A., Kim, J.-B., DeBoer, A.T., Wei, K., et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 457, 490, 2009.